Annual Commercialisation Award

Prof Kevin Kavanagh of Biology receiving the Annual Commercialisation Award presented by Prof Ray O'Neill, VP for Research, flanked by Paul Tyndall and John Scanlan of the Commercialisation Office
Monday, February 13, 2017 - 16:15

Each year the Commercialisation Office recognises excellence in the commercialisation of research at Maynooth University.  We consider activity such as invention disclosures recorded, licence deals completed, new patents filed, spinout company creation and developing new links with industry as key factors in bringing research to the market place.  The 2016 Annual Commercialisation Award was awarded to Professor Kevin Kavanagh of the Biology Department.  

Kevin and the Promoters Nick Duggan and Padraig Maughan formed Rosadex Limited to develop and commercialise a therapy for Ocular Rosacea. Kevin has identified the precise method of action involved in the development and recurrence of the condition.  Ocular rosacea involves irritation to the eye and eyelids and can result in loss of vision. He recently identified and protected formulations that may represent a novel way of treating this condition.